IP Library Assignment 057145/0992
Patent Assignment
Reel/Frame 057145/0992

Assignment of Assignor's Interest

Recorded: 2021-08-11 Pages: 2
Assignors
HEIDMANN, BIBIA
Executed: 2019-11-16
VON RAUMER, MARKUS
Executed: 2019-11-15
Assignee
IDORSIA PHARMACEUTICALS LTD
HEGENHEIMERMATTWEG 91, ALLSHWIL, 4123, SWITZERLAND
Covered Property (1)
Crystalline Form of N-[1-(5-Cyano-Pyridin-2-Ylmethyl)-1 H-Pyrazol-3-Yl]-2-[4-(1-Trifluo-Romethyl-Cyclopropyl)-Phenyl]-Acetamide
Application: 17/345,844 →
Publication: US 2021/0300894
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Patent Security Agreement Jun 25, 2026
From: IDORSIA PHARMACEUTICALS LTD
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 076038/0461 →